Elon Musk's brain-implant company Neuralink on Thursday said it received the US Food and Drug Administration's (FDA) approval to launch first-in-human clinical study.
The company announced the decision on Twitter, saying the approval "represents an important first step that will one day allow our technology to help many people."
Published: undefined
On at least four occasions since 2019, Musk has predicted that his medical device company would soon start human trial of a brain impant to treat intractable conditions like paralysis and blindness.
But the company, founded in 2016, did not seek approval until early 2022.
Published: undefined
Follow us on: Facebook, Twitter, Google News, Instagram
Join our official telegram channel (@nationalherald) and stay updated with the latest headlines
Published: undefined